Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CStone Approved to Market Precision Medicine Drug for AML Patients

publication date: Feb 11, 2022

Suzhou CStone Pharma (HK: 2616) was approved to market Tibsovo® (ivosidenib tablets) in China for adult patients with relapsed/refractory acute myeloid leukemia who have a susceptible IDH1 mutation. About 75 thousand new cases of leukemia are diagnosed each year in China, 59% of whom are AML patients including up to 10% with IDH1 mutations. Tibsovo is an oral targeted IDH1 inhibitor that offers a new precision medicine for the condition. In a China bridging study, Tibsovo® produced a complete response in 37% of these patients. The approval is CStone's fourth in China. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here